Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Platelets|February 15, 2018
Structure and function of the open canalicular system - the platelet's specialized internal membrane networkMaria V Selvadurai, Justin R HamiltonThrombosis and Haemostasis|December 1, 2021
The PAR4 Platelet Thrombin Receptor Variant rs773902 does not Impact the Incidence of Thrombotic or Bleeding Events in a Healthy Older PopulationMaria V Selvadurai, Moeen Riaz, Sophia Xie, et al.Blood Reviews|July 23, 2008
Protease-activated receptors as targets for antiplatelet therapyJustin R HamiltonFEBS Letters|November 14, 2018
The PI 3-kinase PI3KC2α regulates mouse platelet membrane structure and function independently of membrane lipid compositionMaria V Selvadurai, Rose J Brazilek, Mitchell J Moon, et al.Seminars in Thrombosis and Hemostasis|January 27, 2023
Mechanisms of Thrombosis in Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic ThrombocytopeniaMaria V Selvadurai, Emmanuel J Favaloro, Vivien M ChenAnnual Review of Pharmacology and Toxicology|September 14, 2016
Challenges and Opportunities in Protease-Activated Receptor Drug DevelopmentJustin R Hamilton, JoAnn TrejoPharmacology & Therapeutics|February 14, 2012
Physiology, pharmacology, and therapeutic potential of protease-activated receptors in vascular diseaseHannah Lee, Justin R HamiltonPlatelets|September 30, 2017
Perinatal lethality of Par4-/- mice delivered by primiparous dams reveals spontaneous bleeding in mice without platelet thrombin receptor functionShauna L French, Justin R HamiltonBritish Journal of Pharmacology|February 5, 2016
Protease-activated receptor 4: from structure to function and back againShauna L French, Justin R HamiltonInternational Journal of Molecular Sciences|November 14, 2019
Using PAR4 Inhibition as an Anti-Thrombotic Approach: Why, How, and When?Simeng Li, Volga Tarlac, Justin R HamiltonPageof 6